Nafamostat

DRUG2 trials

Sponsors

Seoul National University Hospital, Beijing Chao Yang Hospital

Conditions

ECMOLiver TransplantationPostreperfusion Syndrome

Phase 4

Effect of Nafamostat on Postreperfusion Syndrome (PRS)

CompletedNCT01001403

Seoul National University HospitalLiver Transplantation, Postreperfusion Syndrome

Start: 2009-03-31End: 2010-04-30Updated: 2010-05-11

Unknown Phase

A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation

RecruitingNCT06676085

Beijing Chao Yang HospitalECMO

Start: 2025-05-10End: 2027-12-31Target: 140Updated: 2026-09-09